The company has started enrolling patients into a run-in period for the Phase III study, and plans to begin dosing later this ...

Find out how scientists are maximizing retinal organoid effectiveness to sustain critical retinal ganglion cells.

Many genetic variants linked to inherited eye disorders rarely lead to disease, meaning up to 2% of people could carry these variants without ever developing vision problems, according to a new s tudy ...

Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...

Reduced optic nerve head blood flow seems to be correlated with impaired pupil response in patients with glaucoma.

Greenland sharks may have a DNA repair mechanism that maintains their vision for centuries, seemingly preventing retinal ...

Researchers from Bonn and Basel have developed a new method to equip human retinal organoids – small, lab-grown models of the ...

In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

“The non-invasive in vivo optical imaging of rhodopsin activation extends the diagnostic capability of ORG and may facilitate ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that dosing is complete in ...